PJWCreative, Author at HighField Bio

July 17, 2022 in References

Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer

PJWCreative 0 Like Post Comments Off

April 12, 2022 in Publications

Frontiers in Immunology : Sustained Drug Release from Liposomes for the Remodeling of Systemic Immune Homeostatis and the Tumor Microenvironment

PJWCreative 0 Like Post Comments Off

Click here

January 10, 2022 in Publications

Pharmaceutical Research: Biodistribution and Non-linear Gene Expression of MRNA LNPs Affected by Delivery Route and Particle Size

PJWCreative 0 Like Post Comments Off

Click here

August 31, 2021 in References

Surface Ligand Valency and Immunoliposome Binding: when More Is Not Always Better

PJWCreative 0 Like Post Comments Off

August 31, 2021 in Publications

Pharmaceutical Research: Surface Ligand Valency and Immunoliposome Binding: When More is Not Always Better

PJWCreative 0 Like Post Comments Off

Click here

August 24, 2021 in Uncategorized

Open for Business, Physical Distancing

PJWCreative 0 Like Post 0 Comment

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus hendrerit. Pellentesque aliquet nibh nec urna. In nisi neque, aliquet vel, dapibus id, mattis vel, nisi. Sed pretium, ligula sollici ...

August 23, 2021 in Uncategorized

Fun to Customize

PJWCreative 0 Like Post 0 Comment

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus hendrerit. Pellentesque aliquet nibh nec urna. In nisi neque, aliquet vel, dapibus id, mattis vel, nisi. Sed pretium, ligula sollici ...

August 22, 2021 in Uncategorized

Seven Tips to Improve The Online Shopping

PJWCreative 0 Like Post 0 Comment

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus hendrerit. Pellentesque aliquet nibh nec urna. In nisi neque, aliquet vel, dapibus id, mattis vel, nisi. Sed pretium, ligula sollici ...

August 21, 2021 in Uncategorized

Sending Love From Our Team

PJWCreative 0 Like Post 0 Comment

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Phasellus hendrerit. Pellentesque aliquet nibh nec urna. In nisi neque, aliquet vel, dapibus id, mattis vel, nisi. Sed pretium, ligula sollici ...

ASCO 2025 Abstract: First in human PK analysis of antibody conjugated liposome encapsulating doxorubicin (HF-K1) in advanced cancer patients: Comparison with ADCs.

AACR 2025 Poster: Myeloid cell targeted immune modulation in solid tumor and brain tumor patients: an analysis of NCTO5388487 phase 1 study data.

HighField Biopharmaceuticals Files INDs for Two ADCplex™ Immunoliposomes with Different Cancer Killing Payloads to Overcome Limitations of Current ADCs

HighField Biopharmaceuticals’ Clearance for Phase 2 Trial of HF1K16, a Unique Myeloid Cell Directed Immune Modulator, Follows Phase 1 Results to be Presented at AACR 2025 Meeting

Studies by HighField Biopharmaceuticals Show Advantages of Lipid Structure Design for Applying LNP Non-Viral Gene Therapies to Complex Diseases

HighField Biopharmaceuticals Granted Clearance of IND in China for Clinical Trial of its Unique TRAFsomeTM T Cell Engager (HF50) To Treat Solid Tumor Cancers

Liposomal T cell engager and re-director for tumor cell eradication in cancer immunotherapy

Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer

Frontiers in Immunology : Sustained Drug Release from Liposomes for the Remodeling of Systemic Immune Homeostatis and the Tumor Microenvironment

Pharmaceutical Research: Biodistribution and Non-linear Gene Expression of MRNA LNPs Affected by Delivery Route and Particle Size

Surface Ligand Valency and Immunoliposome Binding: when More Is Not Always Better

Pharmaceutical Research: Surface Ligand Valency and Immunoliposome Binding: When More is Not Always Better

Open for Business, Physical Distancing

Fun to Customize

Seven Tips to Improve The Online Shopping

Sending Love From Our Team